BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36899930)

  • 1. An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization.
    Torricelli F; Sauta E; Manicardi V; Mandato VD; Palicelli A; Ciarrocchi A; Manzotti G
    Cells; 2023 Mar; 12(5):. PubMed ID: 36899930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
    Zador Z; King AT; Geifman N
    PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiscale topology in interactomic network: from transcriptome to antiaddiction drug repurposing.
    Du H; Wei GW; Hou T
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38499497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
    Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
    Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel computational approach for drug repurposing using systems biology.
    Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
    Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Data-driven drug discovery for drug repurposing].
    Saito R; Yano N; Kojima S; Miyoshi F
    Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
    Jadamba E; Shin M
    Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel drug repurposing approach for non-small cell lung cancer using deep learning.
    Li B; Dai C; Wang L; Deng H; Li Y; Guan Z; Ni H
    PLoS One; 2020; 15(6):e0233112. PubMed ID: 32525938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancer.
    Sidorkiewicz I; Jóźwik M; Buczyńska A; Erol A; Jóźwik M; Moniuszko M; Jarząbek K; Niemira M; Krętowski A
    Sci Rep; 2023 Aug; 13(1):13763. PubMed ID: 37612452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function.
    Reay WR; El Shair SI; Geaghan MP; Riveros C; Holliday EG; McEvoy MA; Hancock S; Peel R; Scott RJ; Attia JR; Cairns MJ
    Elife; 2021 Mar; 10():. PubMed ID: 33720009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
    Jiang P; Sun W; Shen N; Huang X; Fu S
    BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
    Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications.
    He H; Duo H; Hao Y; Zhang X; Zhou X; Zeng Y; Li Y; Li B
    Comput Biol Med; 2023 Mar; 155():106671. PubMed ID: 36805225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Drug-repositioning Approach Identifying Sirolimus as a Potential Therapeutic Option for Inflammatory Dilated Cardiomyopathy.
    Shibata K; Endo T; Kuribayashi Y
    Drug Res (Stuttg); 2019 Oct; 69(10):565-571. PubMed ID: 31238376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computational method for drug repositioning using publicly available gene expression data.
    Shabana KM; Abdul Nazeer KA; Pradhan M; Palakal M
    BMC Bioinformatics; 2015; 16 Suppl 17(Suppl 17):S5. PubMed ID: 26679199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
    Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
    Front Immunol; 2019; 10():60. PubMed ID: 30761132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.